Arbutus Biopharma (ABUS) PT Raised to $13 at JMP Securities

October 2, 2017 5:35 PM EDT Send to a Friend
JMP Securities analyst Liisa Bayko raised her price target on Arbutus Biopharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login